Ozempic

Following a surge in demand for its weight-loss drug Wegovy and diabetes medication Ozempic, Danish pharmaceutical company Novo Nordisk (NYSE:NVO) has revised its full-year sales and operating profit outlook. Novo Nordisk is now forecasting a sales growth for 2023 in local currencies of 32% to 38...

Novo Nordisk A/S (NYSE: NVO) shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney failure on early signs of efficacy. The study has implications for other drugmakers including Eli Lilly And Co (NYSE: LLY) and DaVita...

Eli Lilly & Co. (NYSE:LLY) has been a high-flier among the mega-cap pharma stocks this year, as the company leverages the obesity drug craze. Prominent Tesla investor and Future Fund Manager Gary Black weighed in on the stock’s run-up and its future trajectory. What Happened: Lilly stock...

As the cost of living in the U.S. keeps soaring, Americans seem to be shunning comfort food, despite the necessity to eat. Notably, packaged-food manufacturers are witnessing a significant drop in their product sales. This shift in consumer behavior is sparking curiosity and concern among industry...

PepsiCo (NASDAQ: PEP) is among the food and beverage stocks that could see declining sales and momentum lost from investors due to new weight loss drugs. Here’s a look at where the soft drink and snack giant stands ahead of its third-quarter (Q3) financial results. Earnings Estimates: Pepsi...

New side effects of the ‘miracle’ weight loss drug Ozempic are emerging, causing concern among patients and healthcare professionals alike. As reported by Salon, Ozempic, commonly used for weight loss and diabetes management, is coming under scrutiny for potential long-...

In a post on X last Friday, Elon Musk drew attention to the potential impact of Ozempic on food sales at major retailer Walmart Inc. (NYSE: WMT). What Happened: Musk expressed his astonishment, suggesting that the drug could influence consumer purchasing behaviors at the retail giant. ...

Stocks in the food and beverage industry experienced their most challenging week since May 2022, further extending the declines seen in the preceding weeks. The First Trust Nasdaq Food & Beverage ETF (NYSE:FTXG) plummeted by over 5% this week, marking its third consecutive week of losses and...

Walmart Inc. (NYSE:WMT) indicates that there has been a decrease in shopping demand due to the use of appetite-suppressing medications such as Ozempic and Wegovy. According to a report by Bloomberg, Walmart, based in Bentonville, Arkansas, is analyzing changes in sales trends using anonymized...

TV personality, Sharon Osbourne, has decided to quit using the popular weight loss drug, Ozempic, after losing more weight than she originally intended, DNyuz reported. The 70-year-old shared her decision during her appearance on Talk TV’s “Piers Morgan Uncensored” alongside her...

Coca-Cola Co (NYSE:KO) is recognized globally as a beverage giant with roughly 200 brands under its name and products consumed over two billion times each day. Though traditionally viewed as an emblem of American enterprise and stability in fluctuating markets, a Thursday short report by Edwin...

The family of a man who died by suicide is seeking a warning label on the ‘miracle’ weight loss drug Ozempic, claiming it contributed to his death, NBC News reported. The family believes the man’s mood changes were linked to his use of Type 2 diabetes medicine. The man,...

Patients with type 1 diabetes could possibly cease daily insulin injections thanks to the “miracle” weight loss drug Ozempic originally developed to combat type 2 diabetes, Metro News reported. A small-scale study concluded that the results could potentially bring about the...

Roxy Jacenko, an Australian influencer, revealed that she was rushed to the hospital following an overdose of the diabetes drug Ozempic, Pedestrian reported.  Jacenko admitted in an interview with The Daily Telegraph that she had taken Ozempic, popularly used for weight loss and...

Danish biopharma Novo Nordisk A/S (NYSE:NVO) is reaping windfalls from its weight-loss drugs Ozempic and Wegovy, which continue to fly off the shelves. What Happened: In a significant move, Novo Nordisk’s shares on the Copenhagen stock exchange closed Friday...